There seems to be a lot of low quality research on Ivermectin wrt Covid - study design that can only fail to demonstrate anything, errata, and some downright fraud. Is this typical or an outlier?
-
-
-
And if an outlier, why? Is it because not matter how poor your research is, it will get attention?
End of conversation
New conversation -
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.